A novel HIV treatment model using private practitioners in South Africa
- Craig Innes1,
- Robin Hamilton1,
- Christopher J Hoffmann1,2,
- Piotr Hippner1,
- Katherine Fielding3,
- Alison D Grant4,
- Gavin J Churchyard1,
- Salome Charalambous1
- 1The Aurum Institute, Johannesburg, South Africa
- 2Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
- 3Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK
- 4Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
- Correspondence to Dr Craig Innes, PostNet Suite # 300, Private Bag X30500, Houghton, 2041, South Africa;
Contributors CI: support with protocol development, data collection, analysis and manuscript development; RH: support with protocol development and manuscript development; CJH: support with data collection and review of manuscript; KF: support with protocol development, data collection and review of manuscript; ADG: support with protocol development, data collection and review of manuscript; GJC: support with protocol development and manuscript review; SC: protocol development, data collection, analysis and manuscript development.
- Accepted 26 October 2011
Objectives The extent of the HIV epidemic in South Africa may render the public sector capacity inadequate to manage all patients requiring antiretroviral treatment (ART). Private practitioners are an underutilised resource.
Methods The authors developed a model of care using 72 private practitioners in five provinces in urban and rural areas of South Africa with centralised clinical support, training, pharmacy control and data management. The authors describe the programme, its quality control measures and patient outcomes using a cohort analysis.
Results Between January 2005 and December 2008, 9102 individuals were started on ART, 62% female, median age 34 years, median viral load 50 655 copies/ml and median baseline CD4 count 123 cells/μl. Retention (alive and in care) after 12 months was 63% in the 2005 cohort (646 of 1026) and remained similar in the other calendar years, 58%, 68% and 64% in 2006, 2007 and 2008, respectively. After 36 months, retention was 50% and 41% for those enrolled in 2005 and 2006, respectively. The percentage virally suppressed remained similar at 6 months, 82% vs 84%, 84% and 85% from 2005, 2006, 2007 to 2008, respectively, p=0.66; but improved slightly at 12 months, 78% vs 83%, 83% and 84% from 2005 to 2008, p=0.05. At 36 months, it was 84% and 82% for the 2005 and 2006 cohorts, respectively.
Conclusions The results show that a well-managed private practitioner model can achieve comparable results to public services, although long-term retention needs further evaluation. This model of ART delivery can be used to expand access to ART in areas where the public sector is unable to meet the demand.
Funding CJH received funding from the National Institute of Health grant number AI083099.
Competing interests None.
Ethics approval Ethics approval was provided by University of KwaZulu-Natal, South Africa, and the London School of Hygiene and Tropical Medicine, UK.
Provenance and peer review Commissioned; externally peer reviewed.